Jacobs Institute for Design Innovation

Imperative Care Unveils New Structure to Elevate Care for Patients with Vascular Diseases

Retrieved on: 
Thursday, August 10, 2023

The company was founded with a singular focus on transforming stroke care from detection through recovery and making better treatment available to more patients.

Key Points: 
  • The company was founded with a singular focus on transforming stroke care from detection through recovery and making better treatment available to more patients.
  • This focus has since expanded to develop treatments for other devastating ischemic diseases, such as pulmonary embolism and peripheral vascular disease.
  • Imperative Care is now the parent company of four businesses that share a common purpose to bring more care to more people affected by stroke and other ischemic diseases.
  • Imperative Care Vascular (formerly TRUVIC Medical, which was acquired by Imperative Care in 2021), a business unit advancing innovative treatments for people suffering from devastating vascular diseases, including pulmonary embolism.

New Data Shows Advantages of Rapid Medical’s COMANECI™ Embolization Assist Device

Retrieved on: 
Wednesday, July 19, 2023

Rapid Medical ™, a leading developer of advanced neurovascular devices, today announced new clinical data showing significant advantages of its novel COMANECI™ embolization assist device over established techniques to treat ruptured wide-neck intracranial aneurysms.

Key Points: 
  • Rapid Medical ™, a leading developer of advanced neurovascular devices, today announced new clinical data showing significant advantages of its novel COMANECI™ embolization assist device over established techniques to treat ruptured wide-neck intracranial aneurysms.
  • “The COMANECI device is a highly useful adjunct tool for patients with subarachnoid hemorrhage.
  • It has been used in over 12,000 procedures worldwide in wide-neck aneurysm treatments–and in Europe only–to open arteries constricted by vasospasm.
  • However, COMANECI-assisted coiling showed significantly lower thromboembolic and aneurysmal complication rates and periprocedural complications–than both SAC and BAC.

Innovating an Icon: With plant-based, hemp selvedge, and circular versions of its iconic 501®, Levi’s® is showing that even one of the most classic apparel items in modern history can be a platform for innovation with a sustainability lens.

Retrieved on: 
Tuesday, July 11, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230711138725/en/
    The Plant-Based 501® is made of at least 97% plant-based materials, with all certified organic cotton, natural dyestuff, a plant-based patch and ink made from wood waste.
  • They are an evolution in the company’s design innovation practice, building on past seasons and establishing new foundations on which to build going forward.
  • These will come in a variety of shades and finishes for women and men alike, some featuring natural dyes.
  • Each material component aligns with a strict single-fiber strategy that enables efficient recycling at the end of the garment’s useful life.

Storyblok partners with UC Berkeley to design the future of digital content

Retrieved on: 
Wednesday, April 19, 2023

SAN FRANCISCO, Calif., April 19, 2023 /PRNewswire/ -- Storyblok, the content management system (CMS) category leader that empowers both developers and marketing teams to create better content experiences across all digital channels, today announced the results of a design challenge conducted in partnership with UC Berkeley's Jacobs Institute for Design Innovation. Students and alumni with backgrounds in areas like human-computer interaction, cognitive science, and mechanical engineering were asked to develop concepts imagining what the future of websites and digital content will look like.

Key Points: 
  • Thirty participants were organized into five teams for a two-day design sprint guided by Jacobs design instructors Kuan-Ju Wu and Chris Myers .
  • "In this design challenge, we embarked on a journey to explore what the future holds for digital content and our relationship with it.
  • Storyblok was built to be a future-proof CMS that's ready for whatever the future may bring, so we thought it would be interesting to partner with UC Berkeley to get an early look at the future of digital content.
  • We look forward to the time when these concepts become a reality," said Dominik Angerer, Co-Founder and CEO of Storyblok.

Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute

Retrieved on: 
Monday, March 20, 2023

The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.

Key Points: 
  • The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.
  • The new site at Gates Vascular Institute marks the third approved COMMAND trial location, joining Mount Sinai Health System in New York and the University of Pittsburgh Medical Center.
  • The FDA granted Breakthrough Device designation to Synchron in August 2020 and an IDE in July 2021.
  • There is no guarantee of participation and principal investigators make the final determination of patient eligibility.

NovaSignal Donates NovaGuide™ 2 Intelligent Ultrasound to The Jacobs Institute to Advance Stroke Research

Retrieved on: 
Tuesday, February 28, 2023

A non-profit vascular medical technology innovation center, the Jacobs Institute operates at the forefront of developing the next generation of medical technology for the treatment of vascular disease.

Key Points: 
  • A non-profit vascular medical technology innovation center, the Jacobs Institute operates at the forefront of developing the next generation of medical technology for the treatment of vascular disease.
  • The robotic NovaGuide 2 Intelligent Ultrasound makes it easier for healthcare professionals to monitor patients during medical procedures.
  • “Vascular disease research continues to evolve and advance because of companies like NovaSignal,” said Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health.
  • “We’re honored to receive this donation and to continue the important research about stroke related events following cardiac procedures.

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

Retrieved on: 
Tuesday, October 11, 2022

Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health, will moderate each webinar.

Key Points: 
  • Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health, will moderate each webinar.
  • "We are excited to partner with the Jacobs Institute, Dr. Siddiqui, and the University of Buffalo Department of Neurosurgery to bring together leading experts to discuss the evolution in treatment for intracranial bleeding," said Will Martin, President and CEO of IRRAS.
  • IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients.
  • The information was released for public disclosure, through the agency of the contact person above, on October 11, 2022, at 8:30 (CET).

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

Retrieved on: 
Tuesday, October 11, 2022

Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health, will moderate each webinar.

Key Points: 
  • Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health, will moderate each webinar.
  • "We are excited to partner with the Jacobs Institute, Dr. Siddiqui, and the University of Buffalo Department of Neurosurgery to bring together leading experts to discuss the evolution in treatment for intracranial bleeding," said Will Martin, President and CEO of IRRAS.
  • IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients.
  • The information was released for public disclosure, through the agency of the contact person above, on October 11, 2022, at 8:30 (CET).

Tineco CARPET ONE Wins Silver Award at the 2022 International Design Excellence Awards

Retrieved on: 
Monday, September 19, 2022

SEATTLE, Sept. 19, 2022 /PRNewswire/ -- Tineco, pioneer in the field of smart home appliances engineered to elevate modern lifestyles and consumer experience with advanced designs and innovative technology, has been awarded a 2022 IDEA Silver Award for the CARPET ONE and was an IDEA "featured finalist" for the FLOOR ONE S5 Combo.

Key Points: 
  • Hosted by the Industrial Designers Society of America (IDSA), IDEA is one of the world's top three design awards, alongside Germany's iF Design Award and Red Dot Design Award.
  • Key criteria for evaluation includes Design Innovation, Benefit to User, Benefit to Society, and others.
  • The Tineco CARPET ONE, a smart carpet and upholstery cleaner available in North America and most European countries, took home a Silver award while the FLOOR ONE S5 Combo was a Finalist this year.
  • The CARPET ONE Series and the FLOOR ONE S5 Series are available on the Tineco website and among major retailers.

Canon Medical’s All-New 12”×16” High-Definition (Hi-Def) Imaging Detector Provides Highest Resolution in the Market to Help Clinicians See Fine Details

Retrieved on: 
Tuesday, November 23, 2021

The 1216 Hi-Def detector provides more than twice the spatial resolution1 of conventional flat panel detectors, helping clinicians see fine details in complex interventional procedures.

Key Points: 
  • The 1216 Hi-Def detector provides more than twice the spatial resolution1 of conventional flat panel detectors, helping clinicians see fine details in complex interventional procedures.
  • The new 1216 detector joins the existing 1212 Hi-Def detector to provide clinicians with the ideal size for their unique procedural needs.
  • Now available on aforementioned Canon Alphenix interventional systems, the 1216 Hi-Def flat panel detector offers the highest resolution in the market.
  • Documented testing has demonstrated imaging capability with up to 2.5 times greater spatial resolution than conventional detectors.